Location: Home
  • search
  • go
  • Relate News
  • 9/30/2022CDE Solicits Comments on Draft Technical Guidelines for Nonclinical St...
  • 9/30/2022Drug R&D and Product Registration News Digest August 2022 (4)
  • 9/30/2022Financial-related Company News Digest (September 2022)
  • 9/30/2022Be Patient and Lay Low If You Can, Until the Path Forward Reveals Itse...
  • 9/29/2022More MNCs Are Partnering with Chinese Drugmakers in Licensing Deals (P...
  • 9/29/2022FDA Blasts Chinese API Producer Tianyu Pharma for Repeated GMP Shortf...
  • 9/28/2022Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou
  • 9/28/2022Qiming Venture: 'Overinvested' China Healthcare Sector Set for Shake U...
  • 9/28/2022China's Focus to Develop Domestic Medical Device Industry May Discoura...
  • 9/28/2022Seagen and Zai Lab Enter License Pact for Anticancer TIVDAK in Greater...
  • 9/28/2022CDE Issues the Technical Guidelines for Drug Clinical Dependence Resea...
  • 9/28/2022China Forms 12th Chinese Pharmacopoeia Commission to Compile 2025 Edit...
  • 9/28/2022MNCs Witnessed China Performance Slump in Q2/2022
  • 9/28/2022Merck and Sinopharm Enter Import/Distribution Deal for Covid Pill Lage...
  • 9/28/2022Novartis' Sandoz sells Chinese finished drugs plant to CDMO Jiuzhou fo...
  • 9/28/2022Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc
  • 9/28/2022 Allergan Aesthetics Opens Innovation Center in Shanghai
  • 9/28/20223 Steps to Navigate Rare Disease Market in China (PharmExec)
  • 9/28/2022Health Foods in China: New Rules Approving Functional Claims (NLR)
  • 9/28/2022Chinese Market for Treating Breast Cancer with CDK inhibitors to Reach...
  • 9/27/2022WuXi STA Opens First High Potency Oral Drug Product Manufacturing Faci...
  • 9/27/2022CDE Solicits Comments on Two Draft Guidelines on TCM Registration
  • 9/27/2022CDE Issues the List of Reference Formulations for GQCE Studies (59th B...
  • 9/27/2022Legend's Carvykti Wins Japanese Approval for Relapsed or Refractory M...
  • 9/27/2022CDMO Asymchem Plans CNY 5B Manufacturing Facility in Taixing
  • 9/26/2022CDE Solicits Comments on Draft "Technical Guidelines for Research on Q...
  • 9/26/2022CDE Solicits Comments on Draft "Technical Guidelines for Clinical Rese...
  • 9/26/2022KiOmed and Hansoh Enter License Pact for KiOmedinevsOne in Greater Chi...
  • 9/26/2022CASI Pharma Disposes Chinese JV to Strengthen Balance Sheet
  • 9/26/2022Chinese Drugmakers Scramble to Get a Head Start in the iPSC Race (Phar...
  • Page:70/719 Total number of articles:21546: [First][<<] [68] [69] [70] [71] [72] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group